Influence of Different Prostheses on Postoperative Clinical Function in Total Knee Arthroplasty
Launched by THE AFFILIATED NANJING DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL · Sep 25, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different types of knee implants, called prostheses, affect patients' knee function after total knee replacement surgery. Specifically, it compares two types of prostheses: one that keeps the knee's cruciate ligament (CR) and another that stabilizes the knee in a different way (PS). The goal is to understand which type of implant helps patients recover better and have improved movement after surgery.
To participate in the trial, individuals must be between 45 and 80 years old and have a body mass index (BMI) under 35. They should have been diagnosed with severe knee arthritis in both knees and need to have surgery on both knees at the same time. However, those who have had previous knee surgeries or have certain knee conditions may not be eligible. Participants can expect to undergo surgery with one of the two types of prostheses and will be monitored afterward to see how well they can move their knees and perform daily activities. This study is important as it aims to provide valuable insights that could help improve knee replacement outcomes for many patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age 45-80 years, any gender, BMI \< 35 kg/m2
- • 2. Initial diagnosis of bilateral knee OA (Kellgren-Lawrence classification grades 3 or 4). Patients who are to undergo simultaneous primary bilateral knee arthroplasty
- • 3. Inversion deformity ≤ 15°
- • 4. Posterior cruciate ligament integrity
- Exclusion Criteria:
- • 1. History of knee surgery (ligament, osteotomy, etc.)
- • 2. knee flexion\<90°.
- • 3. flexion contracture of one knee \> 10°
- • 4. Comorbidity with other diseases, such as peripheral neuropathy, malignant tumors, rheumatism, etc.
- • 5. Posterior cruciate ligament injury
- • 6. Those assessed to be intolerant of surgery
About The Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School is a leading academic medical institution in China, renowned for its commitment to advanced healthcare, research, and medical education. As a prominent sponsor of clinical trials, the hospital leverages its state-of-the-art facilities and multidisciplinary expertise to facilitate innovative medical research aimed at improving patient outcomes. With a focus on translational medicine, the institution fosters collaborations between clinicians and researchers to accelerate the development of novel therapies and enhance the understanding of complex diseases. Through its rigorous adherence to ethical standards and regulatory compliance, the hospital is dedicated to advancing medical knowledge and contributing to the global scientific community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nanjing, Jiangsu, China
Patients applied
Trial Officials
Zhihong Xu, Doctor
Principal Investigator
Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported